Your browser doesn't support javascript.
loading
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug-Drug Interaction and Improving Clinical Practice.
Le Louedec, Félicien; Puisset, Florent; Chatelut, Etienne; Tod, Michel.
Afiliação
  • Le Louedec F; Institut Claudius-Regaud, Institut Universitaire du Cancer Toulouse, Oncopole, 31059, Toulouse, France.
  • Puisset F; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, Toulouse, France.
  • Chatelut E; Institut Claudius-Regaud, Institut Universitaire du Cancer Toulouse, Oncopole, 31059, Toulouse, France.
  • Tod M; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, Toulouse, France.
Clin Pharmacokinet ; 62(1): 55-66, 2023 01.
Article em En | MEDLINE | ID: mdl-36631685
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Inibidores do Citocromo P-450 CYP3A Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Inibidores do Citocromo P-450 CYP3A Idioma: En Ano de publicação: 2023 Tipo de documento: Article